About Convergent Bioscience
Convergent Bioscience is a company based in Toronto (Canada) founded in 1995 was acquired by ProteinSimple in October 2010. Convergent Bioscience offers products and services including Reagents, Analytical Instruments, and Precision Diagnostics. Convergent Bioscience operates in a competitive market with competitors including Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
ProteinSimple
(Oct 13, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Convergent Bioscience
Convergent Bioscience offers a comprehensive portfolio of products and services, including Reagents, Analytical Instruments, and Precision Diagnostics.
High-quality reagents for cell culture and assays in scientific research
Tools for protein analysis and diagnostics in life sciences
Kits and assays for detecting biomarkers in research applications
Funding Insights of Convergent Bioscience
Detailed funding history for Convergent Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Convergent Bioscience
Convergent Bioscience has secured backing from 1 investor. Prominent investors backing the company include ProteinSimple.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider tools to help researchers with protein analysis
|
Locked | Locked | Locked |
Investor details for Convergent Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Convergent Bioscience
Investment portfolio details for Convergent Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Convergent Bioscience
Detailed financials for Convergent Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Convergent Bioscience Comparisons
Peer comparison for Convergent Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Convergent Bioscience
Convergent Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Diversified instruments are developed for scientific and laboratory management.
|
Detailed competitors of Convergent Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Convergent Bioscience
Complete news archive for Convergent Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Convergent Bioscience
Convergent Bioscience was founded in 1995.
Convergent Bioscience is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Convergent Bioscience offers technology solutions for the product development applications in the pharmaceutical and biotechnology industries. It offers iCE280 Analyzer, a capillary isoelectric focusing solution, which detects focused protein zones using a whole column UV absorption detector that avoids disturbing these focused zones, a PrinCE MicroInjector that provides sample throughput and Alcott Autosampler, which is used when the iCE280 system is used for a large number of injections. In addition, it develops iCE280 CFR software for data acquisition and control and a small molecule. The companys solutions enable to characterize proteins, peptides, and other biologicals. As of October 31, 2010, Convergent Bioscience Ltd. operates as a subsidiary of Cell Biosciences, Inc.
Convergent Bioscience's top competitors include Cepheid, Blackrock Neurotech and Agilent.
Convergent Bioscience offers Reagents, Analytical Instruments, and Precision Diagnostics.
Convergent Bioscience has 1 investor. Key investors include ProteinSimple.